Management of Juvenile Polyposis Syndrome in Children and Adolescents: A Position Paper From the ESPGHAN Polyposis Working Group.


Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 27 12 2018
medline: 26 3 2020
entrez: 27 12 2018
Statut: ppublish

Résumé

The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Polyposis Working Group developed recommendations to assist clinicians and health care providers with appropriate management of patients with juvenile polyposis. This is the first juvenile polyposis Position Paper published by ESPGHAN with invited experts. Many of the published studies were descriptive and/or retrospective in nature, consequently after incorporating a modified version of the GRADE system many of the recommendations are based on expert opinion. This ESPGHAN Position Paper provides a guide for diagnosis, assessment, and management of juvenile polyposis syndrome in children and adolescents, and will be helpful in the appropriate management and timing of procedures in children and adolescents. The formation of international collaboration and consortia is proposed to monitor patients prospectively to advance our understanding of juvenile polyposis conditions.

Identifiants

pubmed: 30585890
doi: 10.1097/MPG.0000000000002246
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-462

Auteurs

Shlomi Cohen (S)

Pediatric Gastroenterology Unit, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Warren Hyer (W)

St Mark's Hospital Polyposis Registry, Harrow, UK.

Emmanuel Mas (E)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS.
Unité de Gastroentérologie, Hépatologie, Nutrition, Diabétologie et Maladies Héréditaires du Métabolisme, Hôpital des Enfants, CHU de Toulouse, Toulouse, France.

Marcus Auth (M)

Alder Hey Children's NHS Foundation Trust, University of Liverpool, Liverpool, UK.

Thomas M Attard (TM)

Department of Gastroenterology, Children's Mercy Hospital, Kansas, MO.

Johannes Spalinger (J)

Children's Hospital Lucerne, LUKS, Lucerne, Switzerland.

Andrew Latchford (A)

St Mark's Hospital Polyposis Registry, Harrow, UK.

Carol Durno (C)

Department of Paediatrics, Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital and The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH